FDA Inspection 788005 — Teva Womens Health, LLC

Teva Womens Health, LLC — FEI 1526814

The FDA completed an inspection of Teva Womens Health, LLC on June 4, 2012 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 4, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116421 CFR 211.28(c)Unauthorized Personnel in Limited Access Areas
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications